Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

New treatments for dry macular degeneration are helping slow vision loss, and researchers are testing therapies that may restore sight. Here’s what to know. Dry age-related macular degeneration is the ...

Age-related macular degeneration is a common cause of blindness, but adding some static noise to a patient’s vision can ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD). A new study, ...

BrightFocus Foundation today announced $15.2 million in new research grants for Alzheimer’s disease, macular degeneration, and glaucoma, reinforcing its commitment to advancing scientific discovery ...

VLTR-559 demonstrates sustained anti-VEGF activity and favorable safety at target clinical dosefor treatment of wetage-related macular ...

Cedars-Sinai investigators working to optimize a cell-based treatment for retinitis pigmentosa have uncovered how transplanted neural stem cells interact with host retinal cells to preserve vision.

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western ...

Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research BrightFocus Foundation today ...